Company: SVREW
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001213900-25-028398
Chunk: 24

Company: SaverOne 2014 Ltd.
Filing Date: 2025-04-03
Form: 424B3
Chunk 24
---
, or the prospectus contained therein is not available for, the issuance of the ADSs for which the Warrants are exercisable. As a result, we may never receive meaningful, or any, cash proceeds from the exercise of the Warrants.

<div align='center'>CAPITALIZATION</div>

The following table sets forth our total capitalization as of December 31, 2024:

| ● | on an actual basis; |

| ● | on pro forma basis, after giving effect to the issuance and sale of 130,620,000 Ordinary Shares represented by 108,850 ADSs (after giving retroactive effect to the new ratio of 1,200 Ordinary Shares for each ADS) for gross proceeds of approximately $0.81 million, which have been issued to Yorkville pursuant to the standby equity purchase agreement dated July 16, 2024, as amended, as if the sale of the securities had occurred on December 31, 2024, as well as the issuance and sale of 195,428,970 Ordinary Shares represented by 162,899 ADSs (after giving retroactive effect to the new ratio of 1,200 Ordinary Shares for each ADS) to several institutional investors in a Registered Direct Offering for gross proceeds of approximately $1.5 million which was completed in January 2025. |
| ● | on a pro forma as adjusted basis, to give further effect any cash exercise of the Warrants, which, if exercised in cash with respect to all of the 404,537,940 Ordinary Shares underlying the Warrants.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

You should read this information in conjunction with our financial statements and the related notes incorporated by reference in this prospectus.

|                                                                                                                                                                                                                                    |     | As of December 31 2024 |          |   |     |               |         |   |     |            |          |   |     |               |         |   |     |            |          |   |     |                       |         |   |
|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-----------------------|---------:|:--|:----|:--------------|--------:|:--|:----|:-----------|---------:|:--|:----|:--------------|--------:|:--|:----|:-----------|---------:|:--|:----|:----------------------|--------:|:--|
|                                                                                                                                                                                                                                    |     | Actual                 |          |   |     |               |         |   |